Drugabilis is the first CRO specialized in pharmaceutical drugability for research. Expertise in Human and Animal health solid form characterization and formulation development.

We deliver both experimental support and consulting services to biotechnology and pharmaceutical companies, not-for-profit organizations and complementary CROs. Read more



Drugabilis is a founding member of the French Association

AFSSI Sciences de la Vie.

Joël Vacus, CEO and CSO, was elected at the Presidence of AFSSI in March 2019.



Follow us on LinkedIn!